• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Mar 1989; 86(5): 1624–1628.
PMCID: PMC286751

Generation of human monoclonal antibodies to human immunodeficiency virus.

Abstract

Based on the finding that cells producing antibodies to human immunodeficiency virus (HIV) circulate in the peripheral blood of HIV-infected individuals, attempts were made to immortalize such B cells with Epstein-Barr virus. Mononuclear cells from 58 HIV-seropositive subjects at various stages of HIV infection were transformed, and anti-HIV cell lines were derived from 4 subjects, all of whom were in early stages of infection. Seven of these cell lines have been stable with respect to antibody production for up to 15 months. Three lines are producing IgG antibody to the 41-kDa HIV transmembrane glycoprotein gp41 and 4 produce IgG antibodies to the 24-kDa HIV core protein p24, its precursors and a breakdown product. The antibodies are reactive by ELISA, by radioimmunoprecipitation, and by Western blot, demonstrating the feasibility of producing multiple stable cell lines synthesizing human monoclonal antibodies to HIV by immortalization of peripheral blood cells with Epstein-Barr virus.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • James K, Bell GT. Human monoclonal antibody production. Current status and future prospects. J Immunol Methods. 1987 Jun 26;100(1-2):5–40. [PubMed]
  • Stevens RH, Macy E, Morrow C, Saxon A. Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol. 1979 Jun;122(6):2498–2504. [PubMed]
  • Lane HC, Volkman DJ, Whalen G, Fauci AS. In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements. J Exp Med. 1981 Oct 1;154(4):1043–1057. [PMC free article] [PubMed]
  • Melamed MD, Gordon J, Ley SJ, Edgar D, Hughes-Jones NC. Senescence of a human lymphoblastoid clone producing anti-Rhesus(D). Eur J Immunol. 1985 Jul;15(7):742–746. [PubMed]
  • Cote RJ, Morrissey DM, Houghton AN, Beattie EJ, Jr, Oettgen HF, Old LJ. Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci U S A. 1983 Apr;80(7):2026–2030. [PMC free article] [PubMed]
  • Houghton AN, Brooks H, Cote RJ, Taormina MC, Oettgen HF, Old LJ. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma. J Exp Med. 1983 Jul 1;158(1):53–65. [PMC free article] [PubMed]
  • Uchiyama K, Saito H, Tokuhisa T, Imai K, Taniguchi M. High frequency of loss of human kappa light chain expression in mouse-human heterohybridomas. Hybridoma. 1987 Dec;6(6):645–654. [PubMed]
  • Teng NN, Lam KS, Calvo Riera F, Kaplan HS. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci U S A. 1983 Dec;80(23):7308–7312. [PMC free article] [PubMed]
  • Zolla-Pazner S, Pinter A, Mizuma H. Potential use of serotherapy in the prevention and treatment of infection with the human immunodeficiency virus. J Virol Methods. 1987 Aug;17(1-2):45–53. [PubMed]
  • Amadori A, De Rossi A, Faulkner-Valle GP, Chieco-Bianchi L. Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin Immunol Immunopathol. 1988 Mar;46(3):342–351. [PubMed]
  • Yarchoan R, Redfield RR, Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. J Clin Invest. 1986 Aug;78(2):439–447. [PMC free article] [PubMed]
  • Pinter A, Honnen WJ. A sensitive radioimmunoprecipitation assay for human immunodeficiency virus (HIV). J Immunol Methods. 1988 Sep 13;112(2):235–241. [PubMed]
  • Mizuma H, Zolla-Pazner S, Litwin S, el-Sadr W, Sharpe S, Zehr B, Weiss S, Saxinger WC, Marmor M. Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses. Clin Exp Immunol. 1987 Apr;68(1):5–14. [PMC free article] [PubMed]
  • Mizuma H, Litwin S, Zolla-Pazner S. B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters. Clin Exp Immunol. 1988 Mar;71(3):410–416. [PMC free article] [PubMed]
  • Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. [PubMed]
  • Pahwa SG, Quilop MT, Lange M, Pahwa RN, Grieco MH. Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome. Ann Intern Med. 1984 Dec;101(6):757–763. [PubMed]
  • Banapour B, Rosenthal K, Rabin L, Sharma V, Young L, Fernandez J, Engleman E, McGrath M, Reyes G, Lifson J. Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus. J Immunol. 1987 Dec 15;139(12):4027–4033. [PubMed]
  • Desgranges C, Boyer V, Souche S, Sprecher S, Burney A, Gallo RC, Bernard J, Reveil B, Zagury D. Monoclonal antibodies to HIV in a non-infected, immunised volunteer. Lancet. 1988 Apr 23;1(8591):935–936. [PubMed]
  • Evans LA, Homsy JM, Morrow WJ, Gaston I, Sooy CD, Levy JA. Human monoclonal antibody directed against gag gene products of the human immunodeficiency virus. J Immunol. 1988 Feb 1;140(3):941–943. [PubMed]
  • Grunow R, Jahn S, Porstmann T, Kiessig SS, Steinkellner H, Steindl F, Mattanovich D, Gürtler L, Deinhardt F, Katinger H, et al. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus. J Immunol Methods. 1988 Feb 10;106(2):257–265. [PubMed]
  • Zolla-Pazner S, Des Jarlais DC, Friedman SR, Spira TJ, Marmor M, Holzman R, Mildvan D, Yancovitz S, Mathur-Wagh U, Garber J, et al. Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5404–5408. [PMC free article] [PubMed]
  • Brown NA, Miller G. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus. J Immunol. 1982 Jan;128(1):24–29. [PubMed]
  • Veronese FD, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. J Virol. 1988 Mar;62(3):795–801. [PMC free article] [PubMed]
  • Chassagne J, Verrelle P, Dionet C, Clavel F, Barre-Sinoussi F, Chermann JC, Montagnier L, Gluckman JC, Klatzmann D. A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol. 1986 Feb 15;136(4):1442–1445. [PubMed]
  • Copeland TD, Tsai WP, Oroszlan S. Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins. Biochem Biophys Res Commun. 1985 Jan 31;126(2):672–677. [PubMed]
  • Folks TM. Epitope mapping of human immunodeficiency virus: a monoclonal approach. J Immunol. 1987 Dec 15;139(12):3913–3914. [PubMed]
  • Carson DA, Freimark BD. Human lymphocyte hybridomas and monoclonal antibodies. Adv Immunol. 1986;38:275–311. [PubMed]
  • Lefvert AK, Holm G. Idiotypic network in myasthenia gravis demonstrated by human monoclonal B-cell lines. Scand J Immunol. 1987 Nov;26(5):573–578. [PubMed]
  • Calman AF, Busch MP, Vyas GN, McHugh TM, Stites DP, Peterlin BM. Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro. AIDS. 1988 Jun;2(3):185–193. [PubMed]
  • Birx DL, Redfield RR, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med. 1986 Apr 3;314(14):874–879. [PubMed]
  • Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ., Jr Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis. 1984 Dec;130(6):1174–1176. [PubMed]
  • Matthews TJ, Langlois AJ, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9709–9713. [PMC free article] [PubMed]
  • Rook AH, Lane HC, Folks T, McCoy S, Alter H, Fauci AS. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J Immunol. 1987 Feb 15;138(4):1064–1067. [PubMed]
  • Weber JN, Clapham PR, Weiss RA, Parker D, Roberts C, Duncan J, Weller I, Carne C, Tedder RS, Pinching AJ, et al. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet. 1987 Jan 17;1(8525):119–122. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...